CareRay Digital Medical Technology Co., Ltd. (SHA:688607)
China
· Delayed Price · Currency is CNY 56.20
+3.84 (7.33%)
Mar 10, 2026, 3:00 PM CST
SHA:688607 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Operating Revenue | 320.53 | 288.88 | 267.68 | 197.4 | 328.05 | Upgrade
|
| Other Revenue | - | 9.22 | 6.06 | 7.18 | 13.93 | Upgrade
|
| Revenue | 320.53 | 298.1 | 273.74 | 204.57 | 341.98 | Upgrade
|
| Revenue Growth (YoY) | 7.52% | 8.90% | 33.81% | -40.18% | 0.81% | Upgrade
|
| Cost of Revenue | - | 185.59 | 172.69 | 140.88 | 185.19 | Upgrade
|
| Gross Profit | 320.53 | 112.51 | 101.05 | 63.69 | 156.79 | Upgrade
|
| Selling, General & Admin | - | 58.18 | 54.96 | 52.91 | 46.5 | Upgrade
|
| Research & Development | - | 43.72 | 44.6 | 44.52 | 31.87 | Upgrade
|
| Other Operating Expenses | 331.28 | -0.58 | -0.44 | -0.58 | -1.57 | Upgrade
|
| Operating Expenses | 331.28 | 103.87 | 100.5 | 97.2 | 80.6 | Upgrade
|
| Operating Income | -10.76 | 8.63 | 0.56 | -33.51 | 76.19 | Upgrade
|
| Interest Expense | - | -0.75 | -0.51 | -0.37 | -0.21 | Upgrade
|
| Interest & Investment Income | - | 8.01 | 10.22 | 12.51 | 18.9 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.04 | 2.97 | 10.27 | -1.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.23 | 1.06 | -1.12 | -0.55 | -0.44 | Upgrade
|
| EBT Excluding Unusual Items | -10.98 | 17.99 | 12.12 | -11.65 | 93.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -1.15 | 1.41 | 0.11 | -0.34 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0 | 0.19 | -0.04 | - | Upgrade
|
| Asset Writedown | - | -0.02 | - | - | - | Upgrade
|
| Legal Settlements | - | -0.01 | - | - | - | Upgrade
|
| Other Unusual Items | - | 0.87 | 1.58 | 2.67 | 3.44 | Upgrade
|
| Pretax Income | -10.98 | 17.69 | 15.3 | -8.91 | 96.28 | Upgrade
|
| Income Tax Expense | -3.88 | 0.01 | -0.11 | -3.23 | 11.23 | Upgrade
|
| Earnings From Continuing Operations | -7.1 | 17.68 | 15.41 | -5.68 | 85.05 | Upgrade
|
| Minority Interest in Earnings | - | -0.02 | 0 | 0.05 | 0.04 | Upgrade
|
| Net Income | -7.1 | 17.65 | 15.41 | -5.63 | 85.09 | Upgrade
|
| Net Income to Common | -7.1 | 17.65 | 15.41 | -5.63 | 85.09 | Upgrade
|
| Net Income Growth | - | 14.54% | - | - | 13.23% | Upgrade
|
| Shares Outstanding (Basic) | - | 88 | 91 | 94 | 86 | Upgrade
|
| Shares Outstanding (Diluted) | - | 88 | 91 | 94 | 86 | Upgrade
|
| Shares Change (YoY) | - | -2.64% | -3.38% | 9.18% | 30.39% | Upgrade
|
| EPS (Basic) | - | 0.20 | 0.17 | -0.06 | 0.99 | Upgrade
|
| EPS (Diluted) | - | 0.20 | 0.17 | -0.06 | 0.99 | Upgrade
|
| EPS Growth | - | 17.65% | - | - | -13.16% | Upgrade
|
| Free Cash Flow | - | -73.59 | -21.71 | -55.89 | 17.46 | Upgrade
|
| Free Cash Flow Per Share | - | -0.83 | -0.24 | -0.60 | 0.20 | Upgrade
|
| Dividend Per Share | - | 0.061 | 0.054 | - | - | Upgrade
|
| Dividend Growth | - | 12.96% | - | - | - | Upgrade
|
| Gross Margin | 100.00% | 37.74% | 36.92% | 31.13% | 45.85% | Upgrade
|
| Operating Margin | -3.36% | 2.90% | 0.20% | -16.38% | 22.28% | Upgrade
|
| Profit Margin | -2.21% | 5.92% | 5.63% | -2.75% | 24.88% | Upgrade
|
| Free Cash Flow Margin | - | -24.69% | -7.93% | -27.32% | 5.11% | Upgrade
|
| EBITDA | -8.13 | 11.26 | 6.71 | -27 | 82.3 | Upgrade
|
| EBITDA Margin | -2.54% | 3.78% | 2.45% | -13.20% | 24.06% | Upgrade
|
| D&A For EBITDA | 2.63 | 2.63 | 6.15 | 6.51 | 6.11 | Upgrade
|
| EBIT | -10.76 | 8.63 | 0.56 | -33.51 | 76.19 | Upgrade
|
| EBIT Margin | -3.36% | 2.90% | 0.20% | -16.38% | 22.28% | Upgrade
|
| Effective Tax Rate | - | 0.06% | - | - | 11.66% | Upgrade
|
| Revenue as Reported | - | 298.1 | 273.74 | 204.57 | 341.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.